H.R. 5354House111th Congress (2009-2011)Passed House

GEDI Act

Introduced May 20, 2010

Legislative Activity

Stay on top of the latest movement without scrolling through every action

19 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

November 15, 2010

View full timeline
HouseIntro Referral

Introduced in House

May 20, 2010

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

May 20, 2010

HouseCommittee

Referred to the Subcommittee on Health.

May 21, 2010

HouseCommittee

Subcommittee Hearings Held.

September 15, 2010

HouseCommittee

Subcommittee Consideration and Mark-up Session Held.

September 16, 2010

HouseCommittee

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

September 16, 2010

HouseCommittee

Committee Consideration and Mark-up Session Held.

September 23, 2010

HouseCommittee

Ordered to be Reported (Amended) by Voice Vote.

September 23, 2010

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-633.

September 28, 2010

HouseCalendars

Placed on the Union Calendar, Calendar No. 373.

September 28, 2010

HouseFloor

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

September 28, 2010 • 9:33 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H7178-7180)

September 28, 2010 • 9:33 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 5354.

September 28, 2010 • 9:33 PM

HouseFloor

At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Burgess objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn.

September 28, 2010 • 9:36 PM

HouseFloor

Considered as unfinished business. (consideration: CR H7379)

September 30, 2010 • 12:39 AM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR 9/28/2010 H7178-7179)

September 30, 2010 • 12:40 AM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 9/28/2010 H7178-7179)

September 30, 2010 • 12:40 AM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

September 30, 2010 • 12:40 AM

HouseFloor

The title of the measure was amended. Agreed to without objection.

September 30, 2010 • 12:40 AM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

November 15, 2010

Floor Debate

8 members

What members said about H.R. 5354 on the floor

3 Republicans5 Democrats
Diana DeGette
Rep. Diana DeGetteD-CO-1 · Nov 30, 2010

Mr. Speaker, I want to thank Mr. Pallone, the chairman of my subcommittee, who does such wonderful work on these diabetes issues, and also the gentleman from Nebraska. We have served for many, many…

Michael C. Burgess
Rep. Michael C. BurgessR-TX-26 · Sep 28, 2010

Mr. Speaker, I yield myself as much time as I may consume. I rise today in strong support of H.R. 5354. I worked on this bill with Mr. Engel. This bill has gone through regular order and passed the…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Nov 30, 2010

Mr. Speaker, I move to suspend the rules and agree to the resolution (H. Res. 1690) supporting the observance of American Diabetes Month, as amended. Mr. Speaker, I ask unanimous consent that all…

Lee Terry
Rep. Lee TerryR-NE-2 · Nov 30, 2010

I yield myself as much time as I may consume. Mr. Speaker, as a member of the Diabetes Caucus and a former vice chair and member of a regional board that included Nebraska for the American Diabetes…

David Scott
Rep. David ScottD-GA-13 · Nov 30, 2010

Thank you very much. Ladies and gentlemen of the House, with nearly 23 million children and adults in the United States living with this disease, it is, indeed, time to reassess our own fitness and…

Show 4 more
Zachary T. Space
Rep. Zachary T. SpaceD-OH-18 · Nov 30, 2010

Thank you, Mr. Chairman, and thank you, Ms. DeGette, for your leadership on this issue. Mr. Speaker, I sympathize with the new Member from New York. He and Ms. DeGette and I have something in common.…

Tom Reed
Rep. Tom ReedR-NY-29 · Nov 30, 2010

I thank my colleague from Nebraska, and I thank you, Mr. Speaker, for the opportunity to stand tonight and rise in support of H. Res. 1690. I appreciate the opportunity to speak today in regard to…

Eliot L. Engel
Rep. Eliot L. EngelD-NY-17 · Nov 30, 2010

I thank my good friend from New Jersey, the chairman of our subcommittee, who does an excellent job, for yielding to me, and I rise today in support of H. Res. 1690, a resolution supporting the…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Sep 28, 2010

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5354) to establish an Advisory Committee on Gestational Diabetes, to provide grants to better understand and reduce gestational…

Bill Text

4 versions available

Reading Mode
Latest
Referred in SenateIssued November 15, 2010

IIB

111th CONGRESS

2d Session

H. R. 5354

IN THE SENATE OF THE UNITED STATES

November 15, 2010

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To provide grants to better understand and reduce gestational diabetes, and for other purposes.

1.

Short title

This Act may be cited as the Gestational Diabetes Act of 2010 or the GEDI Act.

2.

Gestational diabetes

Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by adding after section 317H the following:

317H–1.

Gestational diabetes

(a)

Understanding and monitoring gestational diabetes

(1)

In general

The Secretary, acting through the Director of the Centers for Disease Control and Prevention, in consultation with the Diabetes Mellitus Interagency Coordinating Committee established under section 429 and representatives of appropriate national health organizations, shall develop a multisite gestational diabetes research project within the diabetes program of the Centers for Disease Control and Prevention to expand and enhance surveillance data and public health research on gestational diabetes.

(2)

Areas to be addressed

The research project developed under paragraph (1) shall address—

(A)

procedures to establish accurate and efficient systems for the collection of gestational diabetes data within each State and commonwealth, territory, or possession of the United States;

(B)

the progress of collaborative activities with the National Vital Statistics System, the National Center for Health Statistics, and State health departments with respect to the standard birth certificate, in order to improve surveillance of gestational diabetes;

(C)

postpartum methods of tracking women with gestational diabetes after delivery as well as targeted interventions proven to lower the incidence of type 2 diabetes in that population;

(D)

variations in the distribution of diagnosed and undiagnosed gestational diabetes, and of impaired fasting glucose tolerance and impaired fasting glucose, within and among groups of women; and

(E)

factors and culturally sensitive interventions that influence risks and reduce the incidence of gestational diabetes and related complications during childbirth, including cultural, behavioral, racial, ethnic, geographic, demographic, socioeconomic, and genetic factors.

(3)

Report

Not later than 2 years after the date of the enactment of this section, and annually thereafter, the Secretary shall generate a report on the findings and recommendations of the research project including prevalence of gestational diabetes in the multisite area and disseminate the report to the appropriate Federal and non-Federal agencies.

(b)

Expansion of gestational diabetes research

(1)

In General

The Secretary shall expand and intensify public health research regarding gestational diabetes. Such research may include—

(A)

developing and testing novel approaches for improving postpartum diabetes testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; and

(B)

conducting public health research to further understanding of the epidemiologic, socioenvironmental, behavioral, translation, and biomedical factors and health systems that influence the risk of gestational diabetes and the development of type 2 diabetes in women with a history of gestational diabetes.

(2)

Authorization of Appropriations

There is authorized to be appropriated to carry out this subsection $5,000,000 for each fiscal year 2012 through 2016.

(c)

Demonstration grants to lower the rate of gestational diabetes

(1)

In General

The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award grants, on a competitive basis, to eligible entities for demonstration projects that implement evidence-based interventions to reduce the incidence of gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes.

(2)

Priority

In making grants under this subsection, the Secretary shall give priority to projects focusing on—

(A)

helping women who have 1 or more risk factors for developing gestational diabetes;

(B)

working with women with a history of gestational diabetes during a previous pregnancy;

(C)

providing postpartum care for women with gestational diabetes;

(D)

tracking cases where women with a history of gestational diabetes developed type 2 diabetes;

(E)

educating mothers with a history of gestational diabetes about the increased risk of their child developing diabetes;

(F)

working to prevent gestational diabetes and prevent or delay the development of type 2 diabetes in women with a history of gestational diabetes; and

(G)

achieving outcomes designed to assess the efficacy and cost-effectiveness of interventions that can inform decisions on long-term sustainability, including third-party reimbursement.

(3)

Application

An eligible entity desiring to receive a grant under this subsection shall submit to the Secretary—

(A)

an application at such time, in such manner, and containing such information as the Secretary may require; and

(B)

a plan to—

(i)

lower the rate of gestational diabetes during pregnancy; or

(ii)

develop methods of tracking women with a history of gestational diabetes and develop effective interventions to lower the incidence of the recurrence of gestational diabetes in subsequent pregnancies and the development of type 2 diabetes.

(4)

Uses of Funds

An eligible entity receiving a grant under this subsection shall use the grant funds to carry out demonstration projects described in paragraph (1), including—

(A)

expanding community-based health promotion education, activities, and incentives focused on the prevention of gestational diabetes and development of type 2 diabetes in women with a history of gestational diabetes;

(B)

aiding State- and tribal-based diabetes prevention and control programs to collect, analyze, disseminate, and report surveillance data on women with, and at risk for, gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, and, for women with a history of gestational diabetes, the development of type 2 diabetes; and

(C)

training and encouraging health care providers—

(i)

to promote risk assessment, high-quality care, and self-management for gestational diabetes and the recurrence of gestational diabetes in subsequent pregnancies; and

(ii)

to prevent the development of type 2 diabetes in women with a history of gestational diabetes, and its complications in the practice settings of the health care providers.

(5)

Report

Not later than 4 years after the date of the enactment of this section, the Secretary shall prepare and submit to the Congress a report concerning the results of the demonstration projects conducted through the grants awarded under this subsection.

(6)

Definition of Eligible Entity

In this subsection, the term eligible entity means a nonprofit organization (such as a nonprofit academic center or community health center) or a State, tribal, or local health agency.

(7)

Authorization of Appropriations

There is authorized to be appropriated to carry out this subsection $5,000,000 for each fiscal year 2012 through 2016.

(d)

Postpartum follow-up regarding gestational diabetes

The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall work with the State- and tribal-based diabetes prevention and control programs assisted by the Centers to encourage postpartum follow-up after gestational diabetes, as medically appropriate, for the purpose of reducing the incidence of gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, the development of type 2 diabetes in women with a history of gestational diabetes, and related complications.

.

Passed the House of Representatives September 30 (legislative day September 29), 2010.

Lorraine C. Miller,

Clerk.